CharlesHSpencerMD

PubMed

• 3 citations
  Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research All...
  Matthew A Sherman, Hanna Kim, Katelyn Banschbach, Amanda Brown, Harry L Gewanter
  Pediatric Rheumatology Online Journal. 2023-01-06
• 1 citations
  Time for change at PROJ in 2021
  Charles H. Spencer, Alberto Martini
  Pediatric Rheumatology Online Journal. 2021-05-01
• 2 citations
  Biologics in refractory idiopathic inflammatory myositis (IIM): What experience in juvenile vs adult myositis tells us about the use of biologics in pediatric IIM
  Anjali Patwardhan, Charles H. Spencer
  Modern Rheumatology. 2021-04-06

Journal Articles

• Quantitative Evaluation of a Pediatric Rheumatology Transition Program  
  Stacy P Ardoin, Paul T Jensen, Robert Rennebohm, Gloria C Higgins, Charles H Spencer, BioMed Central
• The Future of Pediatric Rheumatology is XX.  
  Spencer CH, Pediatric Rheumatology Online J 2003 March-April;1(1):114-18
• Treatment of SLE in children and adolescents in 2003: Is it better to have leukemia.  
  Spencer, CH, Ped Rheum Online J 2003 Jan-Feb;1(1):7-12
• Challenges in Pediatric Rheumatology for 2025.  
  Spencer CH, Ped Rheum Online J 2003 Nov-Dec;1(1):196-203
• Should Pediatric Rheumatology Form an International Organization Commentary.  
  Spencer CH, Pediatric Rheumatology Online Journal 2004 Jan-Feb;2(1):4-6
• Two cases for Diagnosis: Asymmetric Childhood Scleradema or Stiff Skin Syndrome.  
  Morrel D, Challgren E, Spencer C, Pediatric Dermatology 2004;4:233-37
• Transition-Risky business for our sickest kids.  
  Spencer CH, Ped Rheum Online J. 2005 May- June;2(3):199-206
• Non-zero sumness in pediatric rheumatology.  
  Spencer CH, Ped Rheum Online J. 2005 July-August;2(4):330-33
• Medical student education in pediatric rheumatology.  
  Spencer, CH, Ped Rheum Online J 2004 Sept-Oct;411-19
• A Typical North American pediatric rheumatology center  
  Spencer, CH, Ped Rheum Online J 2004 Nov- Dec;2(6):483-86
• Distinguishing between JRA and acute lymphocytic leukemia.  
  Jones, OY, Spencer, CH et al, Pediatrics 2005 May 117(3): e855
• Pediatric Rheumatology – a continuation of Pediatric Rheumatology Online Journal.  
  Alberto Martini, Charles H Spencer, Pediatric Rheumatology 2007, 5:1
• Why should pediatric rheumatology be recognized as a separate subspecialty: an open letter to medical councils and government agencies.  
  Spencer, CH, Pediatric Rheumatology 2007, 5:21
• Lupus anticoagulent and thrombosis following Henoch-Schonlein purpura.  
  Abend NS, Licht DJ, Spencer CH, Pediatr Neurol 2007 May;36 (5):345-7
• Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis.  
  Cimaz R, Coppa GV, Kone-Laut I, Link B, Pastores G, Elorduy MR, Spencer C, Thorne C, Wulffraat N, Manger B, Pediatric Rheumatology 2009, 7:18
• Review for the Generalist: the antinuclear antibody test in children – when to use it and what to do with a positive titer.  
  Malleson PN, MacKinnon Murray J, Sailer-Hoeck Michaela, Spencer, Charles H, PROJ 2010; 8:27
• Are patient surveys valuable as a service-improvement Tool in health services.  
  Patwardhan A, Spencer CH, An overview Journal of Healthcare Leadership 2012:4 1-14
• Bone and Joint Infections.  
  Spencer, C, Cur Opin Rheum, 10: 494-497
• Hip disease in children with JRA.  
  Spencer C, Bernstein B, Cur Opin Rheum
• Methotrexate in resistant juvenile rheumatoid arthritis.  
  Giannini, E., Spencer, C., et al, NEJM 326: 10-15
• Immunogenetic studies of juvenile dermatomyositis.  
  Friedman, J., Pachman, L., Spencer, C., Sullivan, D, Tissue Antigens 21:45
• The course of treated juvenile dermatomyositis.  
  Spencer, C., Hanson, V., Singsen, B., Bernstein, B., Kornreich, H., King,K, J. Pediatr 105:399
• Immunogenetic studies juvenile dermatomyositis: III Study of antibody to organ - specific and nuclear antigens.  
  Pachman, L., Friedman J., Marjowski, M., Jonasson, O., Radvang, R., Sharp, G., Cobb, M., Battles, N., Crowe, W., Fink, C., Hanson, V., Levinson, J., Spencer, C., Sull..., Arthritis Rheum. 28, 2:151
• Fusobacterium Necrophorum sepsis with cerebral infarction.  
  Spencer, C., Slusher, C.W., Sanders C.V., and Aldridge, K.E, South Med J 82,8:1040
• Maternal antibodies to SSA/RO are associated with early onset of disease and male sex among children with systemic lupus erythematosus.  
  Lehman, T.J., Harley, J.B., Santner, T.N., Silverman, E., Petty, R., Spencer, C., Reichlin, M, Arthritis Rheum. 32:1414-1420
• Join now to see all

Books/Book Chapters

• Chronic Disorders in Adolescence. 
  Chapter: Chronic arthritis disease in adolescence 
  Spencer, C., Bernstein, BEditors: Smith, M.PSG Publishing, Boston
• Current Therapy. 
  Chapter: Juvenile rheumatoid arthritis 
  Page 907 - 911Spencer and CEditors: Rachel, RE.W.B. Saunders, PhiladelphiaEdition 9,
• The School Experience of Children with Arthritis: Coping at School in the 1990's and transition into adulthood. 
  Page 1258 - 1297Spencer, C., Fife, R., Rabinovich, EPed Clin N America
• Musculoskeletal pain syndromes in Adolescent Health Care-A Practical Guide. 
  Bernstein B and Spencer C
• Join now to see all

Abstracts/Posters

• Health-related quality of life (HRQL) in female adolescent Lupus (SLE) patients: The impact of a lupus support group.
  Kipta M, Rabinovich E, Spencer C, Wagner-Weiner L, Arthritis Rheum 43: S1263
• HLA DRB1, DQA1, DQB1, and DPB1 alleles in children with juvenile arthritis in three ethnic groups.
  Reveille J.D., Spencer, C.H., Rivas Chacon, R.F., Myones, B, Arthritis Rheum 40: S241
• Prognostic Indicators for Children with Juvenile Arthritis on Long Term Methotrexate Therapy.
  Spencer C., Jones, O., Wagner-Weiner, L., Rabinovich, E, Rev Rheum 64: 245S
• Functional status of children with JRA who were diagnosed and treated by pediatric rheumatologists.
  Bowyer S, Roettcher P, Schikler K, Spencer C, et al, Arthritis Rheum 41, S95
• The short-term safety and efficacy of mycofenolate (Cellcept) in treatment of children with pediatric rheumatic diseases.
  Spencer C, Hickey K, Bartosh S, Arthritis Rheum 42, S48
• The occurrence and course of Epstein-Barr virus infection in childhood lupus.
  Wagner-Weiner L, Spencer C, Rabinovich E, Katz B, Arthritis Rheum 42: S392
• The effects of proteosome inhibitor, MG 115, on FAS mediated aptosis of murine cell lines.
  Yeralan O, Wu T, Spencer C, Argon Y, Arthritis Rheum 42, S264
• Decreased gain in total body mineral density over one year in juvenile rheumatoid arthritis.
  Rabinovich E, Wagner-Weiner L, Spencer C, Arthritis Rheum 42, S392
• A multicentered study on differentiation of new onset acute leukemia from juvenile idiopathic arthritis.
  Yeralan O, Rabinovich E, Gedalia A, Gillies A, Dent P, Ilowite N, Spencer C, Arthritis Rheum 43: S116
• Response of Refractory JRA Patients to Cyclosporine A Therapy.
  Yerolan, O., Rabinovich, E., Wagner-Weiner, L., Spencer, CH, Arthritis Rheum 40: S47
• Assessment of damage in pediatric-onset SLE: A multinational study.
  Buratti S, Ravelli A, Duarte-Salazar S, Ruperto N, Pistorio A, Gerloni V, Falcini F, Corona F, Maldonado-Velasquez M, Berinstain-Manterola R, Reiff A, Shaham B, Bernst..., Arthritis Rheum 43: S322
• Relationship Between Health Related Quality of Life, Disease Activity and Damage in Juvenile-Onset Systemic Lupus Erythematosus.
  Buratti S, Duarte-Salazar C, Ruperto N, Spencer CH, et al, Arthritis Rheum 46: S318
• 2 Year Prospective Study of Bone Mineralization in JRA.
  Rabinovich EC, Spencer CH, Wagner-Weiner, L, Arthritis Rheum 46:S470
• Pulmonary alveolar proteinosis in an eight year old female with systemic juvenile idiopathic arthritis.
  Pinto N, Onel K, Spencer C, Lakser O, Arthritis Rheum 54(9): S505
• Simple measure of impact of lupus erythematosus in youngsters (SMILEY)-validity, internal consistency, and test-retest reliability.
  Moorthy L, Peterson P, Baratelli M, Adams A. Barillas E, McDermott E, Angeles S, Barinstein L, Onel K, Spencer C, Wagner-Weiner L, Levey E, Harrison M, Chalom B, Eulie..., Arthritis Rheum 54(9): S163
• Rituximab therapy in pediatric systemic lupus erythematosus.
  Cruz MC, Onel K, Wagner-Weiner L, Spencer CH, Arthritis Rheum 54(12): F12
• Juvenile dermatomyositis is a different disease in children up to three years of age at onset than in children above three years at onset: Retrospective review of 23 y...
  Patwardhan A, Higgins G, Rennebohm R, Spencer C, Arthritis Rheum 60(9)
• Body mass index at diagnosis affects disease course in juvenile dermatomyositis.
  Patwardhan A Higgins G, Rennebohm R, Spencer C, Arthritis Rheum 60(9)
• Mapping of 5' transcriptional regulatory elements of the interleukin-2 receptor alpha chain.
  Cross, S.L., Wolf, J.B., Halden, N.F., Spencer, C.H., Leonard, W.J, Clinical Research 36, no. 3:403
• Three courses of juvenile dermatomyositis.
  Spencer, C., Kornreich, H., Bernstein, B., King, K., Singsen, B., and Hanson, and V, Arthritis Rheum. 22 6:661
• Circulating immune complexes in juvenile dermatomyositis.
  Spencer, C., Hanson, V., Singsen, B., Bernstein, B., Kornreich, H., and King, K, Arthritis Rheum. 23, 6:701
• Nucleolar antihistones (H) antibodies (Ab) in juvenile dermatomyositis.
  Arroyave, C., Packman, L., Rich, K., Passo, M., Kaine, J., Spencer, C., Nickeson, Jr., R, Arthritis Rheum. 28:4, S25
• Suppressor Inducer (SI) and Helper Inducer (HI) T cell subsets in juvenile rheumatoid arthritis.
  Spencer, C.H., Michalski, J., and Gaumer, R, Arthritis Rheum. 29, 4 (suppl.):S66
• Meeting the Needs of Students with Juvenile Rheumatoid Arthritis in a SNAAP (School Nurse Arthritis Advocacy Program).
  Liburd, N., Spencer, C., Edwards, J, American Rheumatism Association, 51st Annual Meeting, June 9-13, Washington, DC
• The use of medication information sheets in a pediatric rheumatology education program.
  Liburd, N., Spencer, C., Edwards, J, American Rheumatism Association, 51st Annual Meeting, June 9-13, Washington, DC
• Join now to see all

Lectures

• The clinical course of treated juvenile dermatomyositis. 
  American Rheumatism Association National Meeting
• Immune complexes in the sera of patients with juvenile dermatomyositis. 
  American Rheumatism Association National Meeting
• Immunotherapy of collagen-induced arthritis in DBA-1mice: Contrasting effects of monoclonal antibodies to alpha-beta and gamma delta T cells receptors. 
  American College of Rheumatology meeting
• The differentiation of acute leukemia from juvenile idiopathic arthritis. 
  Congress of the Pediatric Rheumatology European Society (PReS)
• The musculoskeletal exam in Pediatric Rheumatology. 
  Park City Meeting V of Pediatric Rheumatology Keystone, CO
• Join now to see all